290 related articles for article (PubMed ID: 30105991)
1. Comparable efficacy of adapalene 0.3% gel and tretinoin 0.05% cream as treatment for cutaneous photoaging.
Bagatin E; Gonçalves HS; Sato M; Almeida LMC; Miot HA
Eur J Dermatol; 2018 Jun; 28(3):343-350. PubMed ID: 30105991
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the cumulative irritation potential of adapalene gel and cream with that of erythromycin/tretinoin solution and gel and erythromycin/isotretinoin gel.
Queille-Roussel C; Poncet M; Mesaros S; Clucas A; Baker M; Soloff AM
Clin Ther; 2001 Feb; 23(2):205-12. PubMed ID: 11293554
[TBL] [Abstract][Full Text] [Related]
3. Tretinoin (0.05% cream vs. 5% peel) for photoaging and field cancerization of the forearms: randomized, evaluator-blinded, clinical trial.
Sumita JM; Miot HA; Soares JLM; Raminelli ACP; Pereira SM; Ogawa MM; Picosse FR; Guadanhim LRS; Enokihara MMSS; Leonardi GR; Bagatin E
J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1819-1826. PubMed ID: 29704456
[TBL] [Abstract][Full Text] [Related]
4. Randomised, controlled trial of the efficacy and safety of adapalene gel 0.1% and tretinoin cream 0.05% in patients with acne vulgaris.
Cunliffe WJ; Danby FW; Dunlap F; Gold MH; Gratton D; Greenspan A
Eur J Dermatol; 2002; 12(4):350-4. PubMed ID: 12095880
[TBL] [Abstract][Full Text] [Related]
5. Adapalene gel 0.1% is better tolerated than tretinoin gel 0.025% among healthy volunteers of various ethnic origins.
Goh CL; Tang MB; Briantais P; Kaoukhov A; Soto P
J Dermatolog Treat; 2009; 20(5):282-8. PubMed ID: 19634042
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of a double-conjugated retinoid cream vs 1.0% retinol cream or 0.025% tretinoin cream in subjects with mild to severe photoaging.
McDaniel DH; Mazur C; Wortzman MS; Nelson DB
J Cosmet Dermatol; 2017 Dec; 16(4):542-548. PubMed ID: 28762645
[TBL] [Abstract][Full Text] [Related]
7. Assessment of adapalene gel for the treatment of actinic keratoses and lentigines: a randomized trial.
Kang S; Goldfarb MT; Weiss JS; Metz RD; Hamilton TA; Voorhees JJ; Griffiths CE
J Am Acad Dermatol; 2003 Jul; 49(1):83-90. PubMed ID: 12833014
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy of adapalene (differin(®)) 0.3% gel in Chilean women with cutaneous photoaging.
Herane MI; Orlandi C; Zegpi E; Valdés P; Ancić X
J Dermatolog Treat; 2012 Feb; 23(1):57-64. PubMed ID: 22007702
[TBL] [Abstract][Full Text] [Related]
9. Skin tolerability and efficacy of combination therapy with hydrogen peroxide stabilized cream and adapalene gel in comparison with benzoyl peroxide cream and adapalene gel in common acne. A randomized, investigator-masked, controlled trial.
Capizzi R; Landi F; Milani M; Amerio P
Br J Dermatol; 2004 Aug; 151(2):481-4. PubMed ID: 15327558
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacy and safety of 0.1% adapalene gel and 0.025% tretinoin cream in the treatment of childhood acanthosis nigricans.
Treesirichod A; Chaithirayanon S; Wongjitrat N
Pediatr Dermatol; 2019 May; 36(3):330-334. PubMed ID: 30883877
[TBL] [Abstract][Full Text] [Related]
11. Cumulative irritation potential of topical retinoid formulations.
Leyden JJ; Grossman R; Nighland M
J Drugs Dermatol; 2008 Aug; 7(8 Suppl):s14-8. PubMed ID: 18724650
[TBL] [Abstract][Full Text] [Related]
12. Cumulative irritation comparison of adapalene gel and solution with 2 tazarotene gels and 3 tretinoin formulations.
Greenspan A; Loesche C; Vendetti N; Georgeian K; Gilbert R; Poncet M; Baker MD; Soto P
Cutis; 2003 Jul; 72(1):76-81. PubMed ID: 12889719
[TBL] [Abstract][Full Text] [Related]
13. A double-blind randomized study comparing the association of Retinol and LR2412 with tretinoin 0.025% in photoaged skin.
Bouloc A; Vergnanini AL; Issa MC
J Cosmet Dermatol; 2015 Mar; 14(1):40-6. PubMed ID: 25603890
[TBL] [Abstract][Full Text] [Related]
14. Use of adapalene in alopecia areata: Efficacy and safety of mometasone furoate 0.1% cream versus combination of mometasone furoate 0.1% cream and adapalene 0.1% gel in alopecia areata.
Unal M
Dermatol Ther; 2018 Jan; 31(1):. PubMed ID: 29193637
[TBL] [Abstract][Full Text] [Related]
15. Cumulative irritancy potential of adapalene cream 0.1% compared with adapalene gel 0.1% and several tretinoin formulations.
Brand B; Gilbert R; Baker MD; Poncet M; Greenspan A; Georgeian K; Soto P
Cutis; 2003 Dec; 72(6):455-8. PubMed ID: 14700217
[TBL] [Abstract][Full Text] [Related]
16. Split-face clinical and bio-instrumental comparison of 0.1% adapalene and 0.05% tretinoin in facial acne.
Piérard-Franchimont C; Henry F; Fraiture AL; Fumal I; Piérard GE
Dermatology; 1999; 198(2):218-22. PubMed ID: 10325486
[TBL] [Abstract][Full Text] [Related]
17. Spotlight on adapalene in acne vulgaris.
Waugh J; Noble S; Scott LJ
Am J Clin Dermatol; 2004; 5(5):369-71. PubMed ID: 15554742
[TBL] [Abstract][Full Text] [Related]
18. Adapalene: a review of its use in the treatment of acne vulgaris.
Waugh J; Noble S; Scott LJ
Drugs; 2004; 64(13):1465-78. PubMed ID: 15212561
[TBL] [Abstract][Full Text] [Related]
19. Novel approach to the treatment of hyperpigmented photodamaged skin: 4% hydroquinone/0.3% retinol versus tretinoin 0.05% emollient cream.
Draelos ZD
Dermatol Surg; 2005 Jul; 31(7 Pt 2):799-804. PubMed ID: 16029670
[TBL] [Abstract][Full Text] [Related]
20. Tolerability comparison of adapalene gel, 0.3% versus tazarotene cream, 0.05% in subjects with healthy skin.
Dosik JS; Arsonnaud S
J Drugs Dermatol; 2007 Jun; 6(6):632-8. PubMed ID: 17668529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
